- Supported exchanges /
- TWO /
- 4743.TWO
Oneness Biotech Co Ltd (4743 TWO) stock market data APIs
Oneness Biotech Co., Ltd. engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan. It operates through New Drug Research and Development, and Agricultural Products Cultivation segments. The company develops ON101, which is in Phase III clinical trials for treating chronic diabetic foot ulcers; and OB318, an anti-cancer drug that is in Phase I clinical trials. It is also developing FB825, which is in Phase IIa clinical trial for treating atopic dermatitis and allergic asthma; FB704A that has completed Phase I clinical trial for the treatment of rheumatoid arthritis; OB318, an anticancer botanical drug of antrodia cinnamomea; SNS812, for the treatment of COVID-19 that is in Phase I clinical trials; and FB918 for the treatment of asthma. In addition, the company engages in the management of agriculture cultivation and trading business; and production and sale of agricultural products. Oneness Biotech Co., Ltd. was incorporated in 2008 and is headquartered in Taipei, Taiwan.
Oneness Biotech Co Ltd Financial Data Overview
| 139 | |
| 139.5 | |
| - | |
| 140 | |
| 138.5 | |
| 128-253.5 | |
| 66 076 M | |
| 477 M | |
| 102 M | |
| -1.07 | |
| 1.486 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Oneness Biotech Co Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 102 M
- EBITDA -684 273 024
- Earnings Per Share -3.14
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Oneness Biotech Co Ltd Earnings via APIs
- Latest Release 2024-02-29
- EPS/Forecast -0.25
Get Oneness Biotech Co Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
